We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Maker Of Antipsychotic Drug Tells Federal Circuit Patent Is Infringed

Mealey's (January 30, 2018, 12:27 PM EST) -- WASHINGTON, D.C. — In a Jan. 26 cross-appellant brief Forest Laboratories LLC argued that although a Delaware federal judge properly determined that two claims of the patented atypical antipsychotic drug Saphris...
To view the full article, register now.